Results 101 to 110 of about 740,964 (300)

Neurologic Manifestations of Long COVID Affect Adult Females More Severely Than Males

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterize differences in neurologic manifestations of postacute sequelae of SARS‐CoV‐2 infection (Neuro‐PASC) between females and males. Methods Cross‐sectional study of the first consecutive 261 posthospitalization Neuro‐PASC (PNP) and 2068 nonhospitalized Neuro‐PASC (NNP) patients evaluated at the Neuro‐COVID clinic between ...
Hannah Kopinsky   +5 more
wiley   +1 more source

SARS-CoV-2 Punctuated Evolution

open access: yes, 2022
   The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) evolved slowly over the first year of the Coronavirus Disease 19 (COVID-19) pandemic with differential mutation rates across lineages. Here, we explore how this variation arose.
Chris Organ (8485672)   +2 more
core   +1 more source

SARS‐CoV: Lessons learned; opportunities missed for SARS‐CoV‐2

open access: yesReviews in Medical Virology, 2020
SummarySARS‐CoV‐2 and Covid‐19 have made a retrospective analysis of other coronavirus diseases important, so this article reviews the history of the SARS‐CoV viral disease from 2003. Standard and clinical chemistry diagnostics were developed in response to the outbreak. The response to SARS is examined to determine if there were lessons learned before
openaire   +4 more sources

Model‐Guided Design of Paper Membrane Architectures for Controlled Flow and Enhanced Diagnostic Sensitivity

open access: yesAdvanced Engineering Materials, EarlyView.
Geometrical modifications on nitrocellulose membranes can result in observable differences in signal intensity relative to a reference membrane (top and bottom left). Using two reference experiments, we have developed a theoretical model that can reproduce the experimentally observed flow changes and provide information on membrane parameters, e.g ...
Maria Dimaki   +2 more
wiley   +1 more source

SARS-CoV-2 infects BCO.

open access: yes, 2022
Immunolabeling of SARS-CoV-2 infected SOF-treated organoid sections stained for TUNEL (white), SARS-CoV-2 N protein (green), and MAP2 (red) by confocal microscopy. Scale bar, 20 μm. The BCOs were fixed and analyzed 7 days post-infection. (MOV)
Simoni H. Avansini (3909700)   +17 more
core   +2 more sources

Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant

open access: yesClinical & Translational Immunology, 2021
Objectives The emergence of a SARS‐CoV‐2 variant with a point mutation in the spike (S) protein, D614G, has taken precedence over the original Wuhan isolate by May 2020.
Cheryl Yi‐Pin Lee   +24 more
doaj   +1 more source

Time course of seroprevalence by neutralization assay, Elecsys® Anti-SARS-CoV-2 S, and Elecsys® Anti-SARS-CoV-2.

open access: yes, 2022
Time course of seroprevalence by neutralization assay, Elecsys® Anti-SARS-CoV-2 S, and Elecsys® Anti-SARS-CoV-2.
Satomi Takei (9538727)   +16 more
core   +1 more source

Covalent Functionalization of 2D Semiconductors: A Roadmap to Advanced Electronic Devices

open access: yesAdvanced Functional Materials, EarlyView.
This Review presents recent advances in the covalent functionalization strategies for two‐dimensional semiconductors and their implementation in modern technologies. Layered materials are modified through diverse molecular chemistries (e.g., thiols, diazonium salts, alkyl halides, and electron‐deficient species) to tailor their surface properties ...
Ramiro Quirós‐Ovies   +2 more
wiley   +1 more source

Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike protein

open access: yesSignal Transduction and Targeted Therapy, 2021
SARS-CoV-2 and SARS-CoV are genetically related coronavirus and share the same cellular receptor ACE2. By replacing the VSV glycoprotein with the spikes (S) of SARS-CoV-2 and SARS-CoV, we generated two replication-competent recombinant viruses, rVSV-SARS-
Hongyue Li   +17 more
doaj   +1 more source

Advanced Materials for Biologics Delivery to Brain Tumors

open access: yesAdvanced Materials, EarlyView.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy